Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license
MyGeneLog™ publishes what a position in the genome means — the gene it sits in, the conditions and medicines it reaches — in plain language, in English and Korean, with a source on every claim. Readers read it free. Companies license it. The standard is the same for both: accurate enough that a physician finds nothing to correct, clear enough that anyone can read it.
| Operated by | narubox™, Austin, Texas, United States |
| Product | MyGeneLog™ — the reference site, the data API with the Gene Knowledge Graph, and a free offline desktop app. Published since 5 September 2026. |
| Scale today | 2,492,294 variant pages · 339,642 graph edges · 3,107 papers cited · 7 dated snapshots with DOIs · 545,873 pages read by AI systems in the last 30 days |
| Languages | English and Korean, every page. |
| What is free | Reading, sharing and non-commercial reuse under CC BY-NC 4.0; the desktop app; the open API for non-commercial use. |
| What is sold | API Pro ($99/month, internal use) · API Business ($599/month, inside a product) · Gene Knowledge Graph Snapshots ($49) · a content and data licence, quoted. Details → |
| Data we do not hold | Anyone's genome. The app reads a file on the reader's own computer; there is no upload path and no account is needed to read. |
| Sources | GWAS Catalog, ClinVar, CPIC, MONDO, dbSNP population studies and the primary literature — each read at source, each cited on the page. PharmGKB / ClinPGx is deliberately not used. |
| Contact | Help & contact · for researchers · security.txt |
Genetics information online is split in two. On one side sit the research databases — precise, authoritative, and impenetrable unless you already have the training. On the other sit consumer sites that are readable but thin, hedged, and often quietly wrong. Almost nobody publishes work that is rigorous and readable, and almost nobody publishes it under a license that lets others build on it.
That gap is the whole reason MyGeneLog™ exists. We are working toward detailed, carefully-sourced coverage of four things and, above all, how they connect:
Each of those already exists somewhere on its own. Variants sit in one database, diseases in another, prescribing guidelines in a third, the chemical senses in the literature of a fourth. They have never been introduced to each other.
The join is the product. A position in your file is not information until it is connected to something — and connected differently, the same position becomes a different kind of answer.
Those joins have a name and a number: the Gene Knowledge Graph — 339,642 edges across 257,364 nodes, every one of them labelled with the evidence behind it. A link a person curated from a cited source is not the same claim as two things turning up in one paper, and this graph never adds the two together. A knowledge graph nobody can count is a slogan, so the number goes with the name every time it appears here.
So a person put on warfarin can reach the exact position their own file contains. A person who tastes soap in cilantro can find out why. A person who cannot digest lactose can see that it leads onward to calcium and vitamin D. None of that requires new science — all of it is already published. It requires the connections to be drawn, and drawn carefully enough that a clinician finds nothing to correct.
Connected, it stops being data and starts being about you.
Every page is written from freely-available published research, in our own words, and cited so you can check us. We say plainly when evidence is strong, when it's weak, and when a popular claim on the internet simply isn't supported — because a resource that only ever confirms what people hope to hear is worthless. Where a number is uncertain, we give the range rather than a tidy figure that looks more confident than the science is.
And we publish it openly. Every page is licensed CC BY-NC 4.0, and the variant dataset is available through a free public API with no key and no signup, so researchers, students, patient groups and clinicians can all build on it with attribution. Commercial use — inside a product, inside a company, or to train a commercial AI system — is licensed, and that is how the work is paid for.
The people above work with Claude Code, an AI coding agent, the way they would work with a colleague: it writes and reviews, a person decides. The collectors behind the catalogue, the fact-checking scripts, the Korean translation pipeline and most of these pages were built that way — in the open, one reviewed change at a time.
It does not run the site. Twenty-two recurring jobs keep this place moving — pulling from the GWAS Catalog, re-checking citations against Europe PMC, sealing a dated Gene Knowledge Graph Snapshot every Monday — and not one of them calls a language model. They are deterministic scripts with fixed quality gates, and anything that fails a gate is refused rather than published. A page written by a machine and checked by a machine is a page nobody has checked.
So the division of labour is plain. The agent does what it is good at: writing code, catching its own mistakes, and doing the unglamorous parts at a pace a person cannot. What it does not do is decide. An operator chooses what is published and what is held back; reviewers read both editions, English and Korean, and read the science. Both have overruled it, including on this page.
This is not a finished catalog we're maintaining — it's one we intend to keep growing, aggressively and without an end date.
The standard we hold ourselves to is simple: a specialist should find our page correct, and their patient should find it readable. Anything that fails either test isn't finished yet.
MyGeneLog™ is also a free Windows desktop app that reads a raw genome file — a VCF, or a raw data export from 23andMe or AncestryDNA — and matches it against this curated set of findings. Your file is parsed in memory on your own computer. Nothing is uploaded, nothing is stored on a server, and there is no account to create. Privacy here isn't a policy promise; it's an architectural fact.
MyGeneLog™ does not perform genetic testing, and it is not affiliated with 23andMe, AncestryDNA, or any clinical testing service. Nothing here diagnoses a condition, predicts what will happen to you, or recommends a treatment. Genetics shifts probabilities; it rarely decides outcomes. For what a result means for you specifically, talk to a doctor or a licensed genetic counselor — and bring the page with you.
MyGeneLog™ is developed and maintained by narubox™. The app is actively maintained — if something goes wrong, or a citation here is wrong, tell us and we'll fix it and ship an update. We'd rather fix it than defend it.
Collecting variants is automated. The rest is not: reading the primary literature, checking each figure against the source it came from, and joining a variant to the conditions, drugs and topics it belongs beside. That work is paid for by the companies that license the data — API Pro and Business, dated snapshots, and the content and data licence. Reading stays free.
Readers who are not customers — a teacher, a patient, a student — sometimes ask how to help. The best help is a correction: if a page is wrong, tell us and it is fixed.
MyGeneLog™ is a free, open reference for genetic variants, the conditions they relate to, and how genetics can affect drug response — plus a free Windows desktop app that reads your own raw genome file (a VCF, or a 23andMe or AncestryDNA export) entirely offline and explains the findings in plain language.
MyGeneLog™ is developed and maintained by narubox. It is independent, and is not affiliated with 23andMe, AncestryDNA, or any clinical genetic testing service.
For non-commercial purposes, yes. Every page and every API response is licensed CC BY-NC 4.0: read, share, translate and build on it with attribution to MyGeneLog™. Commercial use — a product you sell, use inside a company, training or serving a commercial AI system — is licensed in tiers, with the prices stated at /license. The variant dataset is available through a free public JSON API at /api/v1/variants with no API key and no signup.
The connections. Variants live in one public database, diseases in another, drug-prescribing guidelines in a third, and research on smell and taste in a fourth. Each is excellent and each is separate. MyGeneLog™ joins them, so a person prescribed warfarin can reach the exact position their own file contains, and a person who tastes soap in cilantro can find out why. A fourth axis works from the other end: a reader arrives with a topic rather than an rsID — sleep, running, personality — and the topic pages show which of our positions turn up in the same papers. The underlying science is already published — what was missing was anyone drawing the lines between it carefully enough to be worth trusting.
Because it is the rare corner of genetics where the effect is not statistical. Most variants shift a probability a little; a change in an odour or taste receptor changes what a person actually perceives. Two people meet the same molecule and one of them smells nothing at all. The bitter-taste haplotype in TAS2R38 reaches a statistical strength of p = 3 x 10^-199, far beyond anything else on this site. And smell and taste are how we choose what to eat, which connects them directly to the metabolism and disease pages.
Every page is written from freely-available published research — sources such as peer-reviewed papers, MedlinePlus Genetics, GeneReviews, and CPIC pharmacogenomic guidelines — in our own words, with the sources cited on the page so you can check them. Nothing is copied from licensed or paywalled sources. Where the evidence is uncertain we state the range rather than a single tidy figure, and where a popular online claim is not supported by evidence we say so directly.
Continuously. New findings are collected from the public GWAS Catalog every twenty minutes and reviewed, and additional variants are added manually after research review. Installed copies of the desktop app pick up new variants automatically, usually within 24 hours.
No. Your genome file is parsed in memory on your own computer and is never uploaded, stored, or transmitted. There is no server-side genome processing and no account to create — privacy here is an architectural fact, not a policy promise.
No. MyGeneLog™ is informational only. It does not diagnose any condition, predict what will happen to you, or recommend medication or treatment. Genetics shifts probabilities rather than deciding outcomes. For what a result means for you specifically, talk to a doctor or a licensed genetic counselor.
By licensing the data. Reading is free for everyone and non-commercial reuse is free under CC BY-NC 4.0; companies that put the data inside a product, use it inside the company, or train or ground an AI system on it buy a licence — API Pro, API Business, dated snapshots, or a content and data licence, with every price stated at /license. Readers who are not customers can make a one-time contribution if they wish; it has never changed what a page says.
Every typeface here is open-licensed and free to use, including commercially. The site, the share cards and the PDF report are all set in the same three, so an image and the page it came from are the same publication.
Space Grotesk Latin display
Headings, the wordmark, and every English word and number — including on Korean pages, so a name looks the same in both. By Florian Karsten. SIL Open Font License 1.1.
Inter Latin text
Body copy in English. By Rasmus Andersson. SIL Open Font License 1.1.
SUIT Hangul
Every Korean character on the site and in the images. By SUNN. SIL Open Font License 1.1.
DejaVu Sans Mono Identifiers in images
rsIDs and footers inside generated images, where a system monospace is not available to fall back on. Free licence, Bitstream Vera derived.
On the page itself, monospaced text uses whatever your system provides — ui-monospace first — rather than shipping a fourth webfont for gene symbols.
Three fluorescent accents on near-black, and nothing else. Each carries a meaning rather than decorating: one is the brand, one is the affirmative, one is the alarm. A card, a lesson PDF and this page use the same three, which is why an image shared out of context still looks like it came from here.
Cyan #2AF0E0
The brand itself — the wordmark, links, and the primary action on any page. Dark text sits on it, never light.
Lime #C6FF3D
What is settled, present or working: a confirmed figure, a downloadable file, the taster half of a chart.
Magenta #FF3EC9
What needs attention rather than what is wrong — an open question, a caveat, the teacher's notes inside a lesson.
Ink #070910
The ground everything is drawn on, in print as on screen. Not black: a near-black with a trace of blue in it, so the accents read as light rather than as paint.
One accent leads per document and the other two support it, so two lessons opened side by side are distinguishable while both are still recognisably ours. The rule is the point: a fourth colour would have to mean something, and nothing here needs a fourth meaning.